Global Pharmaceutical Contract Manufacturing and Contract Market Growth (Status and Outlook) 2025-2031

The global Pharmaceutical Contract Manufacturing and Contract market size is predicted to grow from US$ 97180 million in 2025 to US$ 142910 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

LPI (LP Information)' newest research report, the “Pharmaceutical Contract Manufacturing and Contract Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Manufacturing and Contract sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Manufacturing and Contract sales for 2025 through 2031. With Pharmaceutical Contract Manufacturing and Contract sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Manufacturing and Contract industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Manufacturing and Contract landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Contract Manufacturing and Contract portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Manufacturing and Contract market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Manufacturing and Contract and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Manufacturing and Contract.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Manufacturing and Contract market by product type, application, key players and key regions and countries.

Segmentation by Type:
Oral
Injectable
API
Other

Segmentation by Application:
Small Medium Enterprise
Large Enterprise

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant

Please note: The report will take approximately 2 business days to prepare and deliver.